Casi Pharmaceuticals Stock Buy Hold or Sell Recommendation

CASI
 Stock
  

USD 1.95  0.02  1.04%   

Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Casi Pharmaceuticals is 'Cautious Hold'. Macroaxis provides Casi Pharmaceuticals buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding CASI positions. The advice algorithm takes into account all of Casi Pharmaceuticals' available fundamental, technical, and predictive indicators you will find on this site.
  
The advice is provided from Casi Pharmaceuticals' buy-and-hold perspective. Continue to Casi Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. We conduct extensive research on individual companies such as Casi Pharmaceuticals and provide practical buy, sell, or hold advice based on selected investing horizon and risk tolerance towards Casi Pharmaceuticals.

Execute Casi Pharmaceuticals Buy or Sell Advice

The Casi Pharmaceuticals recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Casi Pharmaceuticals. Macroaxis does not own or have any residual interests in Casi Pharmaceuticals or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Casi Pharmaceuticals' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Casi PharmaceuticalsBuy Casi Pharmaceuticals
Cautious Hold

Volatility

Details

Hype Condition

Details

Current Valuation

Details

Odds of Distress

Details

Economic Sensitivity

Details

Analyst Consensus

Details

Financial Strenth (F Score)

Details

Financial Leverage

Inapplicable
Details

Reporting Quality (M-Score)

Details
For the selected time horizon Casi Pharmaceuticals has a Mean Deviation of 3.46, Standard Deviation of 4.73 and Variance of 22.35
We provide trade advice to complement the prevailing expert consensus on Casi Pharmaceuticals. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Casi Pharmaceuticals is not overpriced, please confirm all Casi Pharmaceuticals fundamentals, including its debt to equity, market capitalization, and the relationship between the net income and short ratio . Please also double-check Casi Pharmaceuticals number of shares shorted to validate your buy or sell decision is consistent with all fundamental data available and that the company can sustain itself in the current economic cycle.

Casi Pharmaceuticals Trading Alerts and Improvement Suggestions

Casi Pharmaceuticals generated a negative expected return over the last 90 days
Casi Pharmaceuticals may become a speculative penny stock
Casi Pharmaceuticals has high historical volatility and very poor performance
Casi Pharmaceuticals is unlikely to experience financial distress in the next 2 years
The company reported the previous year's revenue of 34.91 M. Net Loss for the year was (32.1 M) with profit before overhead, payroll, taxes, and interest of 17.61 M.
Casi Pharmaceuticals currently holds about 24.57 M in cash with (25.22 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.81.
Casi Pharmaceuticals has a frail financial position based on the latest SEC disclosures
Roughly 33.0% of the company shares are held by company insiders

Casi Pharmaceuticals current analysts advice

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Casi Pharmaceuticals analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Casi Pharmaceuticals analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Mean Price22.67
Target Median Price21.00
Target High Price35.00
Recommendation Mean1.30
Number Of Analyst Opinions3
Target Low Price12.00
Average Consensus Strong Buy
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.

Casi Pharmaceuticals Returns Distribution Density

The distribution of Casi Pharmaceuticals' historical returns is an attempt to chart the uncertainty of Casi Pharmaceuticals' future price movements. The chart of the probability distribution of Casi Pharmaceuticals stock daily returns describes the distribution of returns around its average expected value. We use Casi Pharmaceuticals price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Casi Pharmaceuticals returns is essential to provide solid investment advice for Casi Pharmaceuticals.
Mean Return-0.92Value At Risk-7.27
Potential Upside6.53Standard Deviation4.73
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Casi Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Casi Pharmaceuticals Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Casi Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Casi Pharmaceuticals backward and forwards among themselves. Casi Pharmaceuticals' institutional investor refers to the entity that pools money to purchase Casi Pharmaceuticals' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Zebra Capital Management LlcCommon Shares11.2 K33 K
Zebra Capital Management LlcCommon Shares11.2 K17 K
Zebra Capital Management LlcCommon Shares50.7 K127 K
Zebra Capital Management LlcCommon Shares52.5 K107 K
Zebra Capital Management LlcCommon Shares44.3 K137 K
Yintercept Hong Kong LtdCommon Shares16.2 K25 K
Xtx Topco LtdCommon Shares41.3 K49 K
Note, although Casi Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Casi Pharmaceuticals Cash Flow Accounts

201720182019202020212022 (projected)
Capital Expenditure(934.7 K)(1.13 M)(7.05 M)1.2 M(8.94 M)(9.17 M)
Depreciation Amortization and Accretion117.78 K1.67 M2.58 M3.23 M3.1 M3.34 M
Net Cash Flow or Change in Cash and Cash Equivalents16.4 M40.72 M(30.58 M)3.44 M(18.36 M)(18.84 M)
Issuance Purchase of Equity Shares23.73 M92.27 M3.75 M45.9 M30.48 M31.2 M
Net Cash Flow from Financing23.73 M92.27 M22.05 M47.15 M29.64 M26.82 M
Net Cash Flow from Investing(934.7 K)(21.77 M)(28.06 M)(20.72 M)(20.69 M)(21.24 M)
Net Cash Flow from Operations(6.4 M)(28.58 M)(23.24 M)(25.89 M)(26.84 M)(27.55 M)
Share Based Compensation650.44 K6.12 M7.31 M7.82 M7.77 M6.2 M

Casi Pharmaceuticals Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Casi Pharmaceuticals or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Casi Pharmaceuticals' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Casi Pharmaceuticals stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over DOW
-0.96
β
Beta against DOW1.10
σ
Overall volatility
4.59
Ir
Information ratio -0.2

Casi Pharmaceuticals Volatility Alert

Casi Pharmaceuticals exhibits very low volatility with skewness of -1.34 and kurtosis of 5.41. However, we advise investors to further study Casi Pharmaceuticals technical indicators to ensure that all market info is available and is reliable. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Casi Pharmaceuticals' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Casi Pharmaceuticals' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Casi Pharmaceuticals Fundamentals Vs Peers

Comparing Casi Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Casi Pharmaceuticals' direct or indirect competition across all of the common fundamentals between Casi Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as Casi Pharmaceuticals or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Casi Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing Casi Pharmaceuticals by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Casi Pharmaceuticals to competition
FundamentalsCasi PharmaceuticalsPeer Average
Return On Equity(30.23) %(0.31) %
Return On Asset(15.80) %(0.14) %
Profit Margin(91.97) %(1.27) %
Operating Margin(95.40) %(5.51) %
Current Valuation27.11 M16.62 B
Shares Outstanding139.8 M571.82 M
Shares Owned by Insiders32.69 %10.09 %
Shares Owned by Institutions16.06 %39.21 %
Number of Shares Shorted115.97 K4.71 M
Price to Earning(16.46) X28.72 X
Price to Book2.99 X9.51 X
Price to Sales7.89 X11.42 X
Revenue34.91 M9.43 B
Gross Profit17.61 M27.38 B
EBITDA(31.7 M)3.9 B
Net Income(32.1 M)570.98 M
Cash and Equivalents24.57 M2.7 B
Cash per Share1.81 X5.01 X
Total Debt2.9 M5.32 B
Debt to Equity0.032 %48.70 %
Current Ratio3.21 X2.16 X
Book Value Per Share0.66 X1.93 K
Cash Flow from Operations(25.22 M)971.22 M
Short Ratio1.93 X4.00 X
Earnings Per Share(0.44) X3.12 X
Number of Employees17618.84 K
Beta0.54-0.15
Market Capitalization275.4 M19.03 B
Total Asset17.63 M29.47 B
Retained Earnings(565.27 M)9.33 B
Working Capital13.63 M1.48 B
Current Asset17.15 M9.34 B
Current Liabilities3.51 M7.9 B
   Acquisition by Alexander Zukiwski of 3000 shares of Casi Pharmaceuticals subject to Rule 16b-3 [view details]

Casi Pharmaceuticals Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Casi Pharmaceuticals . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Casi Pharmaceuticals Buy or Sell Advice

When is the right time to buy or sell Casi Pharmaceuticals? Buying financial instruments such as Casi Pharmaceuticals Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
 2020 2021 2022 (projected)
Receivables4.64 M9.8 M10.58 M
Inventories1.36 M1.91 M2.51 M

Use Investing Ideas to Build Portfolios

In addition to having Casi Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Robots And Drones Thematic Idea Now

Robots And Drones
Robots And Drones Theme
Large technology companies that are involved in development and manufacturing of drones, robots, or robotic equipment across mechanical engineering, electrical engineering, mathematics and computer science fields. Drones and robotics are projected to significantly grow in demand in the next 5 years. The Robots And Drones theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Robots And Drones Theme or any other thematic opportunities.
View All  Next Launch
Continue to Casi Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Complementary Tools for analysis

When running Casi Pharmaceuticals price analysis, check to measure Casi Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Casi Pharmaceuticals is operating at the current time. Most of Casi Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Casi Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Casi Pharmaceuticals' price. Additionally, you may evaluate how the addition of Casi Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Is Casi Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Casi Pharmaceuticals. If investors know Casi Pharmaceuticals will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Casi Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
26.8 M
Quarterly Revenue Growth YOY
0.26
Return On Assets
(0.15) 
Return On Equity
(0.27) 
The market value of Casi Pharmaceuticals is measured differently than its book value, which is the value of Casi Pharmaceuticals that is recorded on the company's balance sheet. Investors also form their own opinion of Casi Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Casi Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Casi Pharmaceuticals' market value can be influenced by many factors that don't directly affect Casi Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Casi Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine Casi Pharmaceuticals value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Casi Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.